Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-004893
Filing Date
2015-09-16
Accepted
2015-09-16 17:30:38
Documents
1
Period of Report
2015-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6245
  Complete submission text file 0000899243-15-004893.txt   7839
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address
Mills Kenneth T. (Reporting) CIK: 0001652824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37553 | Film No.: 151110926